The importance of classifying initial co-morbidity in evaluating the outcome of diabetes mellitus.

[1]  A. Feinstein,et al.  A Critique of Methods in Reported Studies of Long-term Vascular Complications in Patients with Diabetes Mellitus , 1973, Diabetes.

[2]  A R Feinstein,et al.  XVII. Synchronous partition and bivariate evaluation in predictive stratification , 1972, Clinical pharmacology and therapeutics.

[3]  G. Knatterud,et al.  Effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. 3. Clinical implications of UGDP results. , 1971, JAMA.

[4]  J. Cornfield.  The University Group Diabetes Program. A further statistical analysis of the mortality findings. , 1971, JAMA.

[5]  A. Feinstein.  XI. Sources of ‘chronology bias’ in cohort statistics , 1971, Clinical pharmacology and therapeutics.

[6]  A. Feinstein.  VII. The rancid sampie, the tilted target, and the medical poll‐bearer , 1971 .

[7]  A R Feinstein,et al.  THE PRE-THERAPEUTIC CLASSIFICATION OF CO-MORBIDITY IN CHRONIC DISEASE. , 1970, Journal of chronic diseases.

[8]  Alvan R. Feinstein,et al.  The epidemiology of cancer therapy. II. The clinical course: data, decisions, and temporal demarcations. , 1969, Archives of internal medicine.

[9]  A R Feinstein,et al.  Clinical epidemiology. 3. The clinical design of statistics in therapy. , 1968, Annals of internal medicine.

[10]  F. Ederer,et al.  Maximum utilization of the life table method in analyzing survival. , 1958, Journal of chronic diseases.

[11]  J BERKSON,et al.  Calculation of survival rates for cancer. , 1950, Proceedings of the staff meetings. Mayo Clinic.